Type 1 diabetes is an autoimmune disease that affects nearly 1.6 million people in the United States. In this disease, self-reactive T cells kill beta cells in the pancreas, destroying the body’s ability to produce insulin. Without insulin, glucose cannot enter cells to produce energy. When people with type 1 diabetes experience a glucose build up in the blood, they can suffer from dehydration, weight loss, nerve and blood vessel damage, organ damage and life-threatening diabetic ketoacidosis.

Our Approach

LJI researchers are exploring the hypothesis that there’s something in the pancreas driving its own destruction in type 1 diabetes. Scientists have found that beta cells draw harmful T cells to the pancreas prior to the onset of clinical signs of diabetes. This work has led LJI scientists to investigate the theory that there’s something wrong with the beta cells themselves.

One goal at LJI is to unravel the roles of different immune cells, cytokines, and other signaling molecules as type 1 diabetes progresses. The team analyzes human pancreas tissues obtained from the Network for Pancreatic Organ Donors with Diabetes (nPOD), and also human isolated islets.

[Read more: Unmasking the pancreas]

By approaching type 1 diabetes from several angles, LJI scientists hope to unlock the root of many autoimmune diseases.

An infectious disease connection

LJI Instructors Mehdi Benkahla, Ph.D., and Estefania Quesada-Masachs, M.D., Ph.D., are investigating how predisposing genes and environmental factors, such as viral infections, may interact and trigger the disease. Several viruses, mainly from the Enterovirus genus have been considered as potential causal agents for type 1 diabetes. Their goals are to shed light on the mechanisms by which viruses trigger or exacerbate type 1 diabetes and to identify potential therapeutic targets to prevent or treat this devastating disease.

A nervous system connection

The pancreas is studded with islets, the cell clusters that house insulin-producing beta cells. In people with type 1 diabetes, the body’s own immune cells head for the islets and start attacking the beta cells. No one knows exactly what triggers this attack.

One clue may lie in the pattern of beta cell death. Many beta cells are killed off in big patches while other beta cells are mysteriously untouched. Something seems to be drawing immune cells to attack specific groups of beta cells while ignoring others.

[Read more: Neuroimmunology]

In a 2020 Science Advances study, LJI researchers reported that the nervous system may be driving this patchy cell die-off. Their new findings in a mouse model suggest that blocking nerve signals to the pancreas could stop patients from ever developing type 1 diabetes.

Examining T cell behavior

It’s long been thought that having “autoreactive” T cells in the pancreas was a sure sign of type 1 diabetes. In 2020, an LJI-led study showed that even healthy people have these cells lurking in the pancreas—in surprisingly high numbers. It appears that high numbers of these T cells in the pancreas are the default—whether you have type 1 diabetes or not. In people with type 1 diabetes, tissue samples showed autoreactive T cells very close to—and even infiltrating—the islets.

As Dr. Quesada-Masachs explains, “Healthy people also have these immune cells, but they do not attack their pancreas, and we actually still do not know why this happens.”

These results add evidence for the theory that type 1 diabetes is not caused by malfunctioning T cells attacking beta cells. Instead, the body is already making these T cells and something in the pancreas is triggering the attack. The findings also suggest that an effective type 1 diabetes therapy would need to be local to the pancreas.

[Read more: A cold case no longer]

Going forward, the researchers plan to take a closer look at how the preproinsulin-specific T cells behave. The team also hopes to investigate other proteins in islets that might attract T cell attacks.

Research Projects

von Herrath
Modeling and detection of viral infections in human pancreas slices

Team: Mehdi Benkahla It is thought that an interaction between predisposing genes and environmental factors, such as viral infections, may

von Herrath
Characterization of HLA class I expression in autoantibody positive and type 1 diabetic donors

Team: Mehdi Benkahla and Somayeh Sabouri Type 1 diabetes (T1D) is an autoimmune disease characterized by increased blood glucose levels

von Herrath
Detailed in-situ characterization of cytokines, immune and endocrine cell in the human pancreas

Team: Sakthi Rajendran, Estefania Quesada-Masachs, Christine Bender Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of

von Herrath
Characterization of in-situ IL17 expression in human pancreas

Team: Sakthi Rajendran, Estefania Quesada-Masachs and Mehdi Benkahla IL-17 is a pro-inflammatory cytokine important in shaping host immune responses against

Expression of HLA class II in human pancreatic tissue sections

Team: Estefania Quesada-Masachs, Sakthi Rajendran Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing β cells are attacked

von Herrath
Exploring toxic effects of T1D patient’s serum in pancreatic β cells

Team: Estefania Quesada-Masachs, Sakthi Rajendran Type 1 diabetes (T1D), an autoimmune disease that usually affects young people, is on the

More research projects